most expensive drugs

Signal Tom Randall VP Endpoints News, Head of Signal Jared Whitlock Features Editor Gene therapies were supposed to be competition-proof. They are scientifically complex, require bespoke manufacturing, often go after small patient populations and can cost millions per dose. But that assumption is being tested by a wave of competitors being developed in China — […]